Skip to content

Scilex Holding Company SCLX Purchase And Exercise Of Prefunded Warrant

Purchase And Exercise Of Prefunded Warrant at other companies

JAN
Janus Living JAN
$187.5M
Palladyne AI Corp. logo
Palladyne AI Corp.PDYN
$1.6M
Maze Therapeutics, Inc. Common Stock logo
Maze Therapeutics, Inc. Common StockMAZE
$250
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$34.4M
JFB Construction Holdings Class A Common Stock logo
JFB Construction Holdings Class A Common StockJFB
$1.07M
GCM Grosvenor Inc. logo
GCM Grosvenor Inc.GCMG
$0-100%

Other financials

Income statement

See full
Revenue$8.6M+72.1%
Gross profit$4.2M+15.1%
Operating income-$32.2M-15.3%
Net income-$45.7M-75.0%
EPS (diluted)-$6.28-178%

Balance sheet

See full
Cash & equivalents$3.4M-42.2%
Total debt$95.4M+130%
Total equity-$249.2M-17.8%
Total assets$293.6M+272%

Cash flow

See full
Operating cash flow-$1.1M-118%
CapEx$33.3K
Free cash flow$920.8K-63.7%

Valuation

See full
Market cap$54.86M+88.7%
Enterprise value$146.86M+120%
P/S1.6×+1.0×

Profitability

See full
Gross margin59.7%-12.3pp
Operating margin-1,034.4%-1,313pp
Net margin-1,162.4%-1,359pp
FCF margin12.2%

Returns & leverage

See full
Return on equity170.9%
Debt / equity0.3×
Current ratio0.1×0.0×

Where this comes from

Reported directly by Scilex Holding Company in its filing.

Tagged under the XBRL concept sclx:PurchaseAndExerciseOfPrefundedWarrant.

The official record: Scilex Holding Company’s 10-K, filed April 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scilex Holding Company's purchase and exercise of prefunded warrant.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scilex Holding Company's purchase and exercise of prefunded warrant?
Scilex Holding Company (SCLX) reported purchase and exercise of prefunded warrant of $27.51M in Q4 2025.
What does purchase and exercise of prefunded warrant mean?
Captures the total cash outlay and subsequent conversion of prefunded warrants into common equity. This metric is used to track the execution of capital raises designed to bypass immediate share count limitations.